KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMY) Shares Repurchased (2017 - 2023)

Bristol Myers Squibb (BMY) has disclosed Shares Repurchased for 12 consecutive years, with $4.0 billion as the latest value for Q3 2023.

  • On a quarterly basis, Shares Repurchased rose 470.61% to $4.0 billion in Q3 2023 year-over-year; TTM through Jun 2024 was $4.0 billion, a 6.37% decrease, with the full-year FY2023 number at $5.2 billion, down 35.57% from a year prior.
  • Shares Repurchased was $4.0 billion for Q3 2023 at Bristol Myers Squibb, up from $905.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $7.0 billion in Q4 2019 to a low of $81.0 million in Q1 2020.
  • A 5-year average of $2.0 billion and a median of $1.4 billion in 2020 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: skyrocketed 2091.36% in 2021, then plummeted 95.0% in 2023.
  • Bristol Myers Squibb's Shares Repurchased stood at $7.0 billion in 2019, then plummeted by 79.07% to $1.5 billion in 2020, then skyrocketed by 87.78% to $2.8 billion in 2021, then decreased by 12.18% to $2.4 billion in 2022, then skyrocketed by 65.56% to $4.0 billion in 2023.
  • Per Business Quant, the three most recent readings for BMY's Shares Repurchased are $4.0 billion (Q3 2023), $905.0 million (Q2 2023), and $250.0 million (Q1 2023).